Hwang, CS et al. Trends in co-prescribing of opioids and benzodiazepines, 2002-2014. A m. J. Prev. Med. 51151–160 (2016).
Kaufmann, CN, Spira, AP, Alexander, GC, Rutkow, L. & Mojtabai, R. Trends in sedative-hypnotic drug prescribing in the United States: 1993-2010. Pharmacoepidemiol. Safe medicine. 25637–645 (2016).
Agarwal, SD & Landon, BE Outpatient Benzodiazepine Prescribing Models in the United States. JAMA Network. Open 2e187399–e187399 (2019).
Maust, DT, Lin, LA & Blow, FC Benzodiazepine use and misuse among adults in the United States. Psychiatrist. To serve. 7097-106 (2019).
Kaufmann, CN, Spira, AP, Depp, CA, and Mojtabai, R. Long-term use of benzodiazepines and non-benzodiazepine hypnotics, 1999-2014. Psychiatrist. To serve. 69235-238 (2018).
Ray, WA, Griffin, MR & Downey, W. Benzodiazepines with long and short elimination half-lives and risk of hip fracture. JAMA 2623303–3307 (1989).
Maust, DT et al. Association of Medicare Part D expansion of benzodiazepine coverage with changes in fall-related injuries and overdoses among Medicare Advantage recipients. JAMA Network. Open 3e202051–e202051 (2020).
Wagner, AK et al. Benzodiazepine use and hip fractures in the elderly: who is most at risk?. Camber. Internal. Med. 1641567-1572 (2004).
Zint, K. et al. Impact of drug interactions, dosage and duration of treatment on the risk of hip fracture associated with benzodiazepine use in the elderly. Pharmacoepidemiol. Safe medicine. 191248-1255 (2010).
Donnelly, K., Bracchi, R., Hewitt, J., Routledge, PA, and Carter, B. Benzodiazepines, Z-drugs, and risk of hip fracture: a systematic review and meta-analysis. PLOS ONE 12e0174730 (2017).
Barbonne, F. et al. Association of road accidents with the use of benzodiazepines. Lancet 3521331–1336 (1998).
Smink, BE, Egberts, AC, Lusthof, KJ, Uges, DR & De Gier, JJ The relationship between benzodiazepine use and traffic accidents. CNS drugs 24639-653 (2010).
Orriols, L. et al. Benzodiazepine-type hypnotics and the associated risk of road accidents. Clin. Pharmacol. The. 89595–601 (2011).
Brandt, J. & Leong, C. Benzodiazepines and Z-drugs: An updated review of major adverse outcomes reported in epidemiological research. Drugs DR 17493-507 (2017).
Tom, SE, Wickwire, EM, Park, Y. & Albrecht, JS Non-benzodiazepine sedative hypnotics and the risk of fall-related injury. Sleep 391009-1014 (2016).
Llorente, MD, David, D., Golden, AG, and Silverman, MA Defining patterns of benzodiazepine use in older adults. J. Geriatr. Neurol Psychiatry. 13150-160 (2000).
Patorno, E., Glynn, RJ, Levin, R., Lee, MP & Huybrechts, KF Benzodiazepines and all-cause mortality risk in adults: a cohort study. BMJ 3585 (2017).
French, DD et al. Effect of concurrent use of benzodiazepines and other drugs on injury risk in a veteran population. Safe medicine. 281141–1150 (2005).
Haagsma, JA et al. The Global Burden of Injury: Incidence, Mortality, Disability Adjusted Life Years and Time Trends from the Global Burden of Disease Study 2013. Inj. Prev. 223–18 (2016).
United States Senate Special Committee on Aging. Falls prevention: national, regional and local solutions to better support older people. https://www.aging.senate.gov/imo/media/doc/SCA_Falls_Report_2019.pdf (2019).
US Department of Transportation National Highway Traffic Safety Administration. Multiple drugs and vehicle accidents: analysis of databases. https://trid.trb.org/view/863878 (2008).
Horn, JR Triple drug interactions. https://www.pharmacytimes.com/view/interactions-0111 (2011).
Watanabe, JH & Yang, J. Hospitalization and the combined use of opioids, benzodiazepines, and muscle relaxants in the United States. Hosp. Pharma. 55286-291 (2020).
Witenko, C. et al. Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain. PT. 39427 (2014).
Petersen, I., Douglas, I. & Whitaker, H. Self-controlled case series methods: an alternative to standard epidemiological study designs. BMJ 3545 (2016).
Leonard, EC et al. Screening to identify signals of drug interactions with opioids resulting in unintended traumatic injury. Biomedical. Pharmacologist. 130110531 (2020).
Leonard, EC et al. Population-based signals of antidepressant drug interactions associated with unintentional traumatic injury. Clin. Pharmacol. The. 110(2), 409–423 (2021).
Nam, YH et al. Severe hypoglycemia and use of warfarin in combination with sulfonylureas or metformin. Clin. Pharmacol. The. 105210-218 (2019).
Nam, YH et al. Sulfonylureas and metformin were not associated with an increased rate of serious bleeding in warfarin users: a self-controlled case series study. Clin. Pharmacol. The. 1081010-1017 (2020).
Hey, NY et al. Concomitant use of angiotensin converting enzyme inhibitors with insulin secretagogues and the risk of severe hypoglycaemia. Clin. Pharmacol. The. 111(1), 218–226 (2022).
Han, X. et al. Biomedical computational approaches to identify drug interactions: application to insulin secretagogues. Epidemiology 28(3), 459–468 (2017).
Zhou, M. et al. Pharmacoepidemiological screening for potential oral anticoagulant drug interactions leading to thromboembolic events. Clin. Pharmacol. The. 108377–386 (2020).
Leonard, EC et al. Thromboembolic and neurological sequelae of antihyperlipidemic drug withdrawal during ongoing warfarin therapy. Science. representing seven1–10 (2017).
Nguyen, TPP, Brensinger, CM, Bilker, WB, Hennessy, S. & Leonard, CE Evaluation of serious bleeding signals during concomitant use of clopidogrel and hypnotic drugs. Biomedical. Pharmacologist. 139111559 (2021).
American College of Surgeons. National Trauma Data Standard: Data Dictionary. https://www.facs.org/quality-programs/trauma/tqp/center-programs/ntdb/ntds/archiveddictionary (2015)
Sears, JM, Bowman, SM, Rotert, M. & Hogg-Johnson, S. A new method for classifying injury severity by diagnosis: validation using data from the Occupational Injuries and Trauma Registry. J. Occup. Rehabilit. 25742–751 (2015).
Centers for Control and Prevention of Disasters. Recommended framework for reporting injury mortality data. MMWR: Recommendations and Reports: Morbidity and Mortality Weekly Report. In Recommendations and Reports/Centers for Disease Control, flight. 46, 1–30 (1997).
Whitaker, HJ, Steer, CD & Farrington, CP Self-controlled case series studies: how rare should a rare, nonrecurring outcome be?. Biom. J 601110-1120 (2018).
Greenland, S. A semi-Bayesian approach to the analysis of correlated multiple associations, with application to a study of occupational cancer mortality. Med Statistics 11219–230 (1992).
Strömberg, U. Empirical Bayes and semi-Bayes fits for a large number of estimates. EUR. J. Epidemiol. 24737–741 (2009).
Musich, S., Wang, SS, Slindee, LB, Ruiz, J. & Yeh, CS Concomitant use of opioids with other centrally active drugs in the elderly. Pop. health management 23286-296 (2020).
He, N., Zhang, W.-Q., Shockley, D. & Edeki, T. Inhibitory effects of H1 antihistamines on CYP2D6 and CYP2C9-mediated metabolic reactions in human liver microsomes. EUR. J. Epidemiol. 57847–851 (2002).
Venkatakrishnan, K., Greenblatt, DJ, von Moltke, LL & Shader, RI Alprazolam is another substrate for human cytochrome P450–3A isoforms. J. Clin. Psychopharmacol. 18256 (1998).
Yuan, R., Flockhart, DA & Balian, JD Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. J. Clin. Pharmacol. 391109-1125 (1999).
Malhotra, B. et al. Effects of the moderate CYP3A4 inhibitor fluconazole on the pharmacokinetics of fesoterodine in healthy subjects. Br.J.Clin. Pharmacol. 72263-269 (2011).
Morgan, ET Impact of infectious and inflammatory diseases on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin. Pharmacol. The. 85434–438 (2009).